This interventional clinical trial, titled “Persuasive Messages for COVID-19 Vaccine Uptake: a Randomized Controlled Trial, Part 1,” enrolled 4,000 human subjects aged eighteen and older and was designed to assess one primary and four secondary endpoints.
